Related Experiment Video
Updated: Jul 5, 2026

Listeria monocytogenes Infection of the Brain
Published on: October 2, 2018
Fungal brain infections
Eileen P Scully1, Lindsey R Baden, Joel T Katz
1Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Purpose Of Review:
Fungal infections of the central nervous system, once a relatively rare occurrence, are increasingly common due to the expansion of immunocompromised populations at risk, and therefore are important to recognize early and manage appropriately.
Recent Findings:
The specific infectious risk posed by novel immune-modifying therapies can, in most cases, be predicted on the basis of the immune target and medication timing. In addition, major advances in noninvasive diagnostic tests (e.g. serum beta glucan and galactomannan assays), and the recent introduction of more effective antifungal therapies, have led to a dramatic improvement in clinical outcomes.
Summary:
The current review provides approaches to patients with suspected central nervous system fungal infections based on host-risk factors, clinical syndromes and specific pathogens.
Insights
Central nervous system fungal infections are rising in immunocompromised individuals. Early recognition and management are crucial, aided by new diagnostics and antifungals for improved outcomes.
Area of Science:
- Infectious Diseases
- Neurology
- Mycology
Background:
- Central nervous system (CNS) fungal infections are increasingly prevalent.
- Immunocompromised populations are at heightened risk.
- Early recognition and appropriate management are critical.
Purpose of the Study:
- To review current approaches for diagnosing and managing CNS fungal infections.
- To highlight the impact of novel immune-modifying therapies on fungal risk.
- To provide guidance based on host factors, clinical presentation, and pathogens.
Main Methods:
- Review of recent literature on CNS fungal infections.
- Analysis of diagnostic advancements, including noninvasive assays (serum beta-D-glucan, galactomannan).
- Evaluation of emerging antifungal therapies and their efficacy.
Main Results:
- Immune-modifying therapies present predictable fungal infection risks based on immune targets and drug timing.
- Advances in noninvasive diagnostics have significantly improved early detection.
- Newer antifungal agents have led to better clinical outcomes.
Conclusions:
- A systematic approach to suspected CNS fungal infections is essential.
- Management strategies should integrate host risk factors, clinical syndromes, and specific fungal pathogens.
- Improved diagnostics and therapeutics offer better prognoses for affected patients.
Related Concept Videos
Cryptococcal Meningitis
Brain Abscess l: Introduction
Fungal Phylum Microsporidia
Fungal Group Zygomycota
Encephalitis l: Introduction
Viral Meningitis

